Skip to main content
. 2009 May 20;5:261–266. doi: 10.2147/ndt.s5421

Table 3.

Mean doses of drugs administered throughout the study

Months 0–1
Months 2–3
Months 4–6
Miln (mg/day) Met (mg/day) Miln (mg/day) Met (mg/day) Miln (mg/day) Met (mg/day)
Responders (n = 46) 43 1264 72 1674 81 1737
Non-responders (n = 12) 46 1563 56 1700 58* 1742
*

p < 0.05.

Abbreviations: Miln, milnacipran; Met, metformin.